USMLE Forum - Largest USMLE Community

Full Version: git 5 - nobegod027
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
A 44-year-old woman with end-stage renal disease and on hemodialysis presents to the physician with abdominal pain. Laboratory tests are positive for hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibody (HBcAb), and hepatitis B early antigen (HBeAg), but negative for anti-hepatitis B surface and anti-hepatitis B early antibodies (anti-HBsAb and anti-HBeAb, respectively).Which of the following is the appropriate treatment for this patient’s disease?

A.. DO NOT TREAT ,BECOS THIS PATIENT LAB TEST ARE CONSISTENCE WITH PREVIOUS HEPATITIS B VACCINATION
B...LAMIVUDIN AND INTERFERON ALPHA
C...LAMIVUDIN AND INTERFERON BETA
D...RIBAVIRIN AND LAMIVUDIN
E...RIBAVIRIN AND PEGYLATED INTERFERON ALPHA

ee
@ DRONA EE IS FOR TREATMENT OF HEPATITIS C, SO EE IS WRONG
B...?
o god ..sorry again
BB
BB
thanks a lot nobegod for qs
YEAH BBB IS RIGHT

ALPHA INTERFERON USE FOR TREATMENT OF HEP B, HEP C , MALIGNANT MELANOMA, KAPOSI SARCOMA
BETA INTERFERON= MULTIPLE SCLEROSIS
GAMA INTERFERON= CHRONIC GRANULOMATOUS DISEASE
agree .. Good qs